Q32 Bio Inc.

2.67
-0.01 (-0.37%)
At close: Feb 14, 2025, 3:59 PM
undefined%
Bid 2.66
Market Cap 32.52M
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) -4.51
PE Ratio (ttm) -0.59
Forward PE n/a
Analyst Hold
Ask 2.79
Volume 160,392
Avg. Volume (20D) 401,621
Open 2.65
Previous Close 2.68
Day's Range 2.63 - 2.73
52-Week Range 2.58 - 53.79
Beta undefined

About QTTB

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular ...

Industry Biotechnology
Sector Healthcare
IPO Date Mar 28, 2018
Employees 42
Stock Exchange NASDAQ
Ticker Symbol QTTB

Analyst Forecast

According to 7 analyst ratings, the average rating for QTTB stock is "Hold." The 12-month stock price forecast is $12.5, which is an increase of 368.16% from the latest price.

Buy 14.29%
Hold 85.71%
Sell 0.00%
Stock Forecasts
5 days ago
-9.43%
Q32 Bio shares are trading lower after Piper Sandl... Unlock content with Pro Subscription
2 months ago
-28.57%
Q32 Bio shares are trading lower after Guggenheim downgraded the stock from Buy to Neutral.